Quick View
| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥71.8B | ¥72.5B | −0.9% |
| Operating Income | ¥4.9B | ¥5.9B | −17.1% |
| Ordinary Income | ¥5.5B | ¥6.4B | −14.8% |
| Net Income | ¥3.8B | ¥4.3B | −12.5% |
| ROE | 3.7% | 4.4% | - |
Executive Summary
FY2025 Q3 results showed revenue of 7.18 billion yen (YoY -0.9%), operating income of 490 million yen (YoY -17.1%), ordinary income of 550 million yen (YoY -14.8%), and net income of 380 million yen (YoY -12.5%). Revenue remained essentially flat while profitability declined across all levels. Gross profit margin held at 30.5%, but operating margin compressed to 6.8% as SG&A expenses of 1.70 billion yen represented 23.7% of sales. The company maintains a conservative balance sheet with equity ratio of 76.4% and cash holdings of 1.40 billion yen. Long-term borrowings decreased 31.8% YoY from 680 million yen to 464 million yen, further strengthening the already robust financial position. However, ROE of 3.7% reflects suboptimal capital efficiency despite minimal financial leverage.
Performance Drivers
Revenue of 7.18 billion yen declined marginally by 0.9% YoY, indicating stable but stagnant top-line performance. The minimal revenue contraction suggests defensive business characteristics, though no visible growth catalyst emerged during the quarter. Cost of sales totaled 4.99 billion yen, yielding gross profit of 2.19 billion yen at a 30.5% margin, demonstrating maintained product profitability at the gross level. The profit deterioration occurred primarily at the operating level, where SG&A expenses of 1.70 billion yen consumed 23.7% of revenue, resulting in operating income of 490 million yen with a 6.8% margin, down 1.3 percentage points from the implied prior year level. This suggests that fixed cost absorption weakened as revenue growth stalled. Non-operating income contributed positively with dividend income of 27 million yen and net non-operating gains totaling approximately 60 million yen, lifting ordinary income to 550 million yen. Special items included gains on sales of investment securities of 9 million yen. The gap between ordinary income of 550 million yen and net income of 380 million yen reflects an effective tax rate of 31.2%, consistent with standard corporate taxation. No extraordinary impairments or restructuring charges were evident. This represents a revenue flat/profit down pattern, driven by operating deleverage from stagnant sales against a relatively fixed cost structure.
Key Metrics
[Profitability] ROE of 3.7% indicates low capital efficiency relative to historical performance and peer standards, while operating margin of 6.8% reflects compressed profitability from SG&A burden. Net profit margin of 5.3% demonstrates reasonable conversion from top-line to bottom-line despite the operating margin pressure. Return on assets of 2.8% (calculated as 3.7% ROE divided by financial leverage of 1.31) indicates modest asset productivity. [Cash Quality] Cash and deposits of 1.40 billion yen provide coverage of 0.60 times short-term liabilities of 2.32 billion yen, though the broader current ratio of 264.7% confirms strong short-term liquidity when including all current assets of 6.15 billion yen. Quick ratio of 250.5% further validates liquidity adequacy. [Investment Efficiency] Asset turnover of 0.533 trails the industry median, indicating room for improvement in asset utilization. Inventory turnover reflected in inventory holdings of 330 million yen suggests reasonable working capital management. However, accounts receivable of 3.04 billion yen representing 22.6% of total assets indicates extended collection cycles requiring close monitoring. [Financial Health] Equity ratio of 76.4% substantially exceeds industry norms, confirming conservative capitalization. Current ratio of 264.7% and debt-to-equity ratio of 0.31 demonstrate minimal financial risk. Interest-bearing debt of 464 million yen represents just 4.3% of total capital, with long-term borrowings decreased 31.8% YoY, further reducing an already minimal debt load.
Cash Flow Analysis
Cash and deposits stood at 1.40 billion yen, representing 10.4% of total assets and 22.7% of current assets, providing adequate liquidity cushion for operational needs. The 31.8% YoY reduction in long-term borrowings from 680 million yen to 464 million yen indicates debt repayment of approximately 216 million yen, suggesting operating cash generation supported deleveraging activities despite profit decline. Working capital composition shows accounts receivable of 3.04 billion yen as the dominant component, while accounts payable management maintains reasonable supplier credit utilization. The company's ability to reduce debt while maintaining stable cash reserves implies that operating activities generated sufficient cash to cover both debt service and working capital requirements. Interest expense of 2 million yen remained minimal, confirming low financial burden. The balance sheet structure with current assets of 6.15 billion yen against current liabilities of 2.32 billion yen provides cash coverage ratio of 2.65 times for short-term obligations, indicating robust liquidity management despite modest profit generation.
Earnings Quality
Ordinary income of 550 million yen compared to operating income of 490 million yen shows net non-operating contribution of approximately 60 million yen, representing 0.8% of revenue. The non-operating account comprises primarily dividend income of 27 million yen and other financial income, indicating modest supplementary earnings from investment portfolio. Special gains on sales of investment securities of 9 million yen represent a minor non-recurring element, constituting just 0.1% of revenue and 2.4% of net income, thus having minimal impact on core earnings sustainability. The effective tax rate of 31.2% aligns with standard corporate tax levels, showing no unusual tax distortions. Interest expense of 2 million yen remains negligible given the 464 million yen debt balance, confirming low financial leverage burden. The progression from operating income through ordinary income to net income shows logical flow without material gaps or discontinuities exceeding 10% thresholds, suggesting earnings are primarily driven by operational performance rather than extraordinary items. The stability of gross margin at 30.5% combined with transparent cost structure indicates reliable earnings foundation, though operating leverage concerns arise from the SG&A ratio relative to flat revenue trends.
Guidance Update
Full-year guidance projects revenue of 9.70 billion yen (YoY +1.0%), operating income of 500 million yen (YoY -21.3%), ordinary income of 550 million yen (YoY -20.7%), and net income of 380 million yen (YoY -21.7%). Nine-month progress rates reach 74.0% for revenue, 98.4% for operating income, 100.0% for ordinary income, and 100.0% for net income. Operating income and ordinary income have already achieved or exceeded full-year targets, suggesting either conservative initial guidance or better-than-expected first-half performance. The revenue progress of 74.0% at Q3 slightly trails the standard 75.0% benchmark but remains within reasonable range. The company faces a full-year forecast implying essentially flat revenue with significant profit decline, reflecting anticipated continuation of margin pressure. The Q3 operating income achievement of 98.4% of full-year target implies minimal incremental operating profit expected in Q4, possibly indicating seasonal factors or management conservatism. EPS guidance of 198.87 yen for full year compares to actual Q3 cumulative of 199.48 yen, showing near-complete achievement. The forecasts incorporate YoY changes of +1.0% revenue growth against operating income decline of -21.3%, suggesting persistent cost structure challenges will continue pressuring profitability despite modest top-line stabilization.
Shareholder Returns
The company projects full-year dividend of 50 yen per share based on forecast data, with supplementary dividend information indicating 60 yen for the period under review. Using the 60 yen per share figure against Q3 cumulative EPS of 199.48 yen yields a payout ratio of 30.1%, which represents moderate shareholder returns within sustainable range. Against full-year forecast EPS of 198.87 yen, the 50 yen dividend guidance implies 25.1% payout ratio, demonstrating conservative dividend policy aligned with profit levels. With net income of 380 million yen and approximately 1.91 million shares outstanding, the 50 yen annual dividend would require approximately 96 million yen in total distributions, representing 25.2% of net income. The company's cash position of 1.40 billion yen provides ample coverage for dividend obligations. No share buyback activities were disclosed. The dividend policy maintains continuity of shareholder returns despite profit decline, supported by strong balance sheet and cash reserves. The payout ratio in the 25-30% range leaves substantial retained earnings for reinvestment while providing consistent income to shareholders.
Risk Factors
Accounts receivable concentration represents elevated working capital risk, with 3.04 billion yen (22.6% of total assets) indicating extended collection cycles that could strain cash conversion. High days sales outstanding compared to industry benchmarks suggests potential credit quality concerns or customer payment term pressures that warrant close monitoring. Operating leverage deterioration poses profitability risk, as evidenced by the 17.1% operating income decline against only 0.9% revenue contraction. The 23.7% SG&A-to-sales ratio indicates limited flexibility to absorb further revenue weakness, creating downside vulnerability if top-line growth does not materialize. Low capital efficiency reflected in 3.7% ROE and 3.6% ROIC indicates suboptimal deployment of the substantial equity base of 10.28 billion yen, suggesting the company may be over-capitalized relative to business opportunities and failing to generate adequate returns for shareholders despite minimal financial risk.
Industry Benchmark (Reference - Proprietary Data)
[Industry Position] (Reference - Proprietary Analysis) The company operates in a competitive industry environment where median performance metrics provide useful context. Profitability comparison shows ROE of 3.7% substantially below industry median of 8.1% (2025-Q3), indicating significant underperformance in capital efficiency. Operating margin of 6.8% exceeds industry median of 4.7%, demonstrating relative strength in operational profitability despite recent compression. Net profit margin of 5.3% aligns closely with industry median of 6.5%, suggesting comparable bottom-line conversion. Financial health metrics show equity ratio of 76.4% far exceeding industry median of 52.3%, confirming exceptionally conservative capital structure that may constrain ROE potential. Current ratio of 264.7% significantly surpasses industry median of 2.03 times, reflecting substantial liquidity buffers. Efficiency metrics reveal asset turnover of 0.533 trailing industry median of 0.82, indicating room for improvement in asset productivity. Revenue growth of -0.9% YoY underperforms industry median growth of +5.7%, highlighting competitive disadvantage in top-line momentum. The company's financial leverage of 1.31 falls well below industry median of 1.90, consistent with the conservative capitalization approach. Overall positioning suggests a financially secure but operationally challenged profile, with industry-leading balance sheet strength offset by below-median growth and returns. (Industry: Food Products sector comparable companies, Comparison: FY2025 Q3 cross-sectional data, Source: Proprietary analysis)
Key Takeaways from Earnings
The earnings data reveals a financially robust company facing operational efficiency challenges, characterized by fortress balance sheet metrics including 76.4% equity ratio and minimal debt burden, yet constrained by low capital productivity with 3.7% ROE substantially below peer median of 8.1%. The divergence between revenue stability (down just 0.9%) and profit decline (operating income down 17.1%) demonstrates operating deleverage that requires strategic cost management attention, particularly given SG&A expenses consuming 23.7% of sales. Progress rates showing operating and ordinary income already achieving 98-100% of full-year guidance by Q3 suggest either conservative initial forecasts or seasonality factors, with minimal incremental profit anticipated in Q4. The company's working capital structure exhibits concentration in accounts receivable at 22.6% of total assets with extended collection cycles, representing both a cash conversion opportunity and a credit quality monitoring point. Shareholder returns policy maintains sustainability with payout ratios in the 25-30% range supported by adequate cash reserves, though the allocation of substantial equity capital to generate sub-4% returns raises questions about optimal capital deployment and potential for enhanced value creation through improved asset utilization or adjusted capital structure.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI Financial Analysis
Executive Summary
Marutai’s FY2026 Q3 earnings were weaker year on year, with modest sales erosion translating into a disproportionate decline in operating profit. Revenue was ¥7.183bn, down 0.9% YoY. Operating income declined 17.1% to ¥492m, while ordinary income fell 14.8% to ¥545m. Net income decreased 12.5% to ¥381m, equivalent to EPS of ¥199.48. The gross margin narrowed by approximately 73bp YoY to 30.5%, as cost of sales increased slightly despite lower sales. The operating margin compressed by approximately 135bp to 6.8%. The net margin declined by approximately 70bp to 5.3%. SG&A expenses rose 1.8% to ¥1.699bn while revenue declined, indicating negative operating leverage and explaining much of the operating-profit shortfall. Non-operating income of ¥54m, including ¥27m of dividend income, supported ordinary income relative to operating income. A ¥9m gain on sale of investment securities also lifted profit before tax, but this was immaterial to the overall earnings trend. The balance sheet remains conservatively capitalized, with equity of ¥10.283bn representing 76.4% of total assets. Liquidity is strong, supported by a 264.7% current ratio and ¥3.829bn of working capital. Interest-bearing debt is limited at ¥464m, and interest coverage is exceptionally high at 317.6x. Receivables rose 16.8% YoY to ¥3.041bn and the 116-day DSO is a material efficiency concern requiring monitoring. The company has already achieved 98.4% of full-year operating-income guidance and 100.3% of net-income guidance after Q3, implying a very weak final quarter under the unchanged forecast. Full-year sales guidance still requires approximately ¥2.517bn of Q4 revenue, while only about ¥8m of Q4 operating income is implied. The principal near-term issue is whether gross-margin pressure and elevated receivables normalize sufficiently to preserve earnings and capital efficiency.
Profitability Analysis
The annualized DuPont ROE is 4.9%, comprising a 5.3% net profit margin, 0.711x annualized asset turnover, and 1.31x financial leverage. The low ROE is principally driven by modest profitability and asset turnover rather than aggressive leverage, consistent with the company’s equity-heavy balance sheet. Net margin fell from approximately 6.0% in the prior-year period to 5.3%, reducing the profit contribution to ROE. Gross margin declined from approximately 31.2% to 30.5%, a compression of about 73bp. Operating margin fell from approximately 8.2% to 6.8%, a larger compression of about 135bp, because SG&A increased 1.8% despite a 0.9% revenue decline. This adverse SG&A-to-sales relationship indicates unfavorable operating leverage and is the most visible factor behind the 17.1% operating-income decline. The annualized asset turnover of 0.711x is moderate for a manufacturing company with a substantial fixed-asset base, including ¥5.886bn of PPE, or 43.7% of total assets. Financial leverage of 1.31x is conservative and limits balance-sheet risk, but it also means profitability improvement must come primarily from margins and asset utilization. The annualized ROA is approximately 3.8%, below the 5% level generally associated with stronger asset productivity. The 4.8% ROIC quality alert reinforces that operating returns are currently below a desirable level for sustained value creation. Its root cause is the combination of sub-scale operating margin relative to the asset base and restrained asset turnover. For a food manufacturer, a mid-single-digit ROIC can occur during periods of input-cost pressure and price-adjustment lag, but the current level leaves limited room for earnings volatility. The investment implication is that margin recovery, utilization of fixed assets, and working-capital discipline are more important to returns than incremental financial leverage. The five-factor decomposition shows a 0.688 tax burden, slightly below the 0.70 normal reference point, while the 1.126 interest burden reflects net non-operating income rather than financing stress. EBIT margin is 6.8%, making cost control and gross-margin stabilization the key operational variables.
Growth Assessment
Revenue fell 0.9% YoY to ¥7.183bn, indicating that the company has not yet returned to top-line growth in the Q3 cumulative period. Cost of sales increased slightly to ¥4.991bn, causing gross profit to decline 3.2% to ¥2.192bn. Accordingly, profit deterioration materially exceeded the revenue decline. Ordinary income fell less than operating income because dividend income and other non-operating income provided support. Net income declined 12.5%, somewhat less than operating income, aided by the modest gain on sale of investment securities and a lower tax expense. Full-year guidance calls for revenue of ¥9.700bn, up 1.0% YoY, and operating income of ¥500m, down 21.3% YoY. Q3 revenue progress is 74.1%, broadly in line with the standard 75% progress rate. Operating-income progress is 98.4%, 23.4 percentage points ahead of the standard Q3 pace. Ordinary-income progress is 99.1%, also 24.1 percentage points ahead of the standard pace. Net-income progress is 100.3%, 25.3 percentage points above standard progress and already marginally above the full-year forecast. Based on the unchanged guidance, Q4 would generate roughly ¥2.517bn of revenue but only ¥8m of operating income and a small net loss of roughly ¥1m. This implied Q4 profile suggests either seasonality, anticipated cost pressure, promotional spending, or conservative guidance maintenance; subsequent disclosure should clarify the driver. Sustained growth will depend on restoring pricing and mix sufficiently to offset manufacturing input costs while preventing SG&A growth from continuing to outpace sales.
Financial Health
Financial health is strong. Current assets of ¥6.153bn exceed current liabilities of ¥2.324bn by ¥3.829bn, producing a current ratio of 264.7%. The quick ratio is also robust at 250.5%, demonstrating that liquidity is not dependent on inventory liquidation. Cash and deposits were ¥1.398bn, while receivables were ¥3.041bn and inventories were ¥330m. Current liabilities are covered by cash, short-term investment securities of ¥1.000bn, and trade receivables, although the receivables collection cycle warrants close monitoring. Total liabilities were ¥3.183bn against equity of ¥10.283bn, equivalent to liabilities-to-equity of 0.31x. Interest-bearing debt was only ¥464m, or approximately 4.5% of equity, and debt-to-capital was 4.3%. Long-term loans declined by ¥216m, or 31.8% YoY, to ¥464m, lowering financial risk and reinforcing the conservative capital structure. The ¥288m current portion of long-term loans is readily covered by liquid current assets, so maturity mismatch risk is limited. Interest coverage of 317.6x indicates very high debt-service capacity. PPE accounts for 43.7% of total assets, reflecting a tangible-asset-intensive manufacturing model, while intangibles represent only 1.3% of assets. Deferred tax liabilities were ¥207m and asset retirement obligations were ¥8m, neither of which changes the overall conclusion of a sound solvency position. The principal balance-sheet operating risk is not leverage but receivables discipline: trade receivables increased ¥438m YoY to ¥3.041bn while revenue declined.
Notable B/S Changes
Long-term loans: -¥2.16bn (-31.8%) to ¥464m - debt reduction further strengthens the already conservative capital structure and reduces refinancing and interest-cost risk.
Cash Flow Quality
Dividend Sustainability
The full-year dividend forecast is ¥50 per share. Against forecast EPS of ¥198.87, the implied dividend payout ratio is approximately 25.1%, which is conservative and well below the 60% sustainability reference level. The forecast dividend represents an aggregate cash commitment of roughly ¥96m based on 1.922 million issued shares. This is modest relative to Q3 net income of ¥381m and retained earnings of ¥5.808bn. The Q2 dividend was ¥0, consistent with a year-end-focused distribution structure under the disclosed forecast. The low payout ratio provides flexibility to maintain the forecast dividend even if final-quarter profitability is weaker than expected. The absence of material interest-bearing debt also reduces the risk that financing demands compete with shareholder distributions. Dividend capacity should nevertheless be assessed alongside receivables collection and recurring operating-profit recovery, because the current earnings trend is negative.
Risk Assessment
Business risks include Margin and input-cost risk: gross margin contracted about 73bp YoY and operating margin contracted about 135bp. As a food manufacturer, Marutai is exposed to volatility in agricultural ingredients, packaging, energy, and logistics costs; incomplete pass-through into selling prices would further pressure profitability., Demand and pricing risk: revenue declined 0.9% YoY, and the company must balance volume retention against price revisions in a consumer food market where competition and private-label alternatives can constrain pricing power., Operating-leverage risk: SG&A rose 1.8% while sales declined, demonstrating that modest revenue weakness can produce a substantially larger decline in operating profit., Capital-efficiency risk: ROIC of 4.8% is below the 5% quality threshold. The root cause is a 6.8% EBIT margin combined with moderate annualized asset turnover on a PPE-heavy asset base. While such returns can be seen in stable food manufacturing, the current level limits value creation and makes earnings more vulnerable to cost shocks. The impact is that higher sales without margin improvement may not materially improve shareholder returns..
Financial risks include Receivables-collection risk: DSO of 116 days exceeds the 60-day quality threshold. Trade receivables increased 16.8% YoY to ¥3.041bn despite lower sales. The root cause may include sales timing, customer payment terms, or slower collections; its impact is greater working-capital absorption and potential pressure on cash conversion., Forecast execution risk: Q3 operating income has reached 98.4% of the full-year forecast, implying only ¥8m of Q4 operating income under unchanged guidance. A material deviation from this implied quarterly profile could affect expectations around guidance conservatism and final-quarter cost trends., Investment-market exposure: investment securities of ¥1.122bn and accumulated valuation gains of ¥530m expose equity to market-value movements, although the overall balance-sheet impact is moderated by high capitalization..
Key concerns include Sustained gross-margin recovery is needed to reverse the decline in annualized ROE to 4.9% and ROIC to 4.8%., Receivable days and the relationship between receivables growth and revenue should be monitored as a leading indicator of collection quality and working-capital efficiency., Management’s explanation for the unusually low implied Q4 operating profit under the maintained full-year forecast is important for evaluating earnings visibility., The company’s low leverage and strong liquidity materially mitigate solvency risk, shifting analytical emphasis toward operating execution rather than refinancing risk..
Investment Implications
Key takeaways include FY2026 Q3 showed revenue softness and significant margin compression, with operating income down 17.1% YoY versus a 0.9% revenue decline., The balance sheet is a clear strength: 76.4% equity ratio, 264.7% current ratio, 4.3% debt-to-capital, and 317.6x interest coverage., Annualized ROE of 4.9%, annualized ROA of approximately 3.8%, and ROIC of 4.8% indicate that profitability and asset utilization require improvement., Full-year profit guidance is effectively achieved by Q3, creating an unusually subdued implied Q4 earnings profile., The forecast ¥50 dividend implies a conservative 25.1% payout ratio and is supported by retained earnings and low leverage..
Metrics to watch include Gross margin and operating margin, particularly evidence that cost inflation is being recovered through price and product mix., SG&A growth relative to sales growth and resulting operating leverage., Trade receivables, DSO, and collection patterns after the 16.8% YoY increase in receivables., Q4 operating income relative to the approximately ¥8m implied by unchanged full-year guidance., ROIC and annualized asset turnover, including utilization of the ¥5.886bn PPE base., Dividend execution relative to the ¥50 per-share full-year forecast..
Regarding relative positioning, Marutai appears financially defensive relative to a leveraged manufacturing profile, with ample liquidity, minimal debt, and very strong interest coverage. Its relative weakness is operating efficiency: a 6.8% operating margin, 4.9% annualized ROE, and 4.8% ROIC place greater importance on margin recovery and receivables management than on balance-sheet repair.